Workshop: Getting the most out of conferences

Workshop: WGS-based pneumococcal species and strain characterization

Workshop: Pandemic preparedness and prediction models for dummies – how to save yourself and the world

Workshop: Back to basics – pneumococcal identification and serotyping with classic techniques

Workshop: How well do pneumococcal vaccines really work? Connecting trial immunogenicity with real-world outcomes

Workshop: Advances in metagenomics, syndromic panels, and PCR for diagnosing airway infections

Industry Sponsored Symposium 01 (not included in the main event CME/CPD credit)

Opening Ceremony

Welcome Reception

Industry Sponsored Symposium 02 (not included in the main event CME/CPD credit)

Plenary 01: Preventing pneumonia and pneumococcal disease in special populations

Parallel 01: Pneumococcal serotype dynamics and genomic diversity

Parallel 02: Clinical Management

Parallel 03: Pneumococcal Immunology and Host Defense

Parallel 04: Childhood Vaccines

Industry Sponsored Symposium 03 (not included in the main event CME/CPD credit)

Plenary 02: Diagnostic and treatment dilemmas posed by changes in pneumonia etiology

E-Poster Spotlight 01: Pneumococcal Biology and Host Response

E-Poster Spotlight 02: Clinical Manifestations and Pneumonia

E-Poster Spotlight 03: Vaccine Development and Immunogenicity

E-Poster Spotlight 04: Epidemiology, Surveillance and AI

Poster Viewing & E-Poster Discussions

MTE 01: Implementation and uptake of new pneumococcal vaccines in immunocompromised populations – barriers and solutions

MTE 02: What to pick – conventional or molecular methods for pneumococcal surveillance

MTE 03: The difficult Streptococcus mitis group

MTE 04: Mediators of mucosal immunity to pneumococcus

Early Career Networking Night

Industry Sponsored Symposium 04 (not included in the main event CME/CPD credit)

Plenary 03: Pneumonia and pneumococcal vaccines in a changing world – climate, conflict, and coverage

Parallel 05: Vaccine Design and Immunogenicity

Parallel 06: Vaccination, AI and Antimicrobial Resistance

Parallel 07: Carriage, Transmission and Ecology

Parallel 08: Innovation and Modelling

Industry Sponsored Symposium 05 (not included in the main event CME/CPD credit)

Plenary 04: Optimising the enfant PCV schedule

E-Poster Spotlight 05: From Bench to Bedside

E-Poster Spotlight 06: Vaccine Impact and Population Health

E-Poster Spotlight 07: Treatment, Outcomes and Resistance

E-Poster Spotlight 08

Poster Viewing & E-Poster Discussions

MTE 05: Pneumococcal disease in an aging world and vaccination strategies

MTE 06: Pneumococcal serotype-specific epidemiology – outbreaks

MTE 07: Pneumococcal pneumonia and evaluation of the immune system – primary immune defects

MTE 08: Pneumococcal vaccine coverage and equity in a changing world

Networking Event TBA

Industry Sponsored Symposium 06 (not included in the main event CME/CPD credit)

Plenary 05: Bacterial and viral interactions

Parallel 09: Vaccine Impact and Effectiveness

Parallel 10: Epidemiology and Disease Burden

Parallel 11: Health Systems and access to Pneumococcal vaccines

Parallel 12: Late-Breaking Abstracts

Bill & Melinda Gates Foundation Session - Maximizing Impact of Pneumococcal Vaccines: Balancing new epidemiological insights, higher valency vaccines and dose optimization

Plenary 06: Hot topics and new ideas – results from Robert Austrian Research Award winners

MTE 09: Global pneumococcal sequence clusters – a guide for the perplexed

MTE 10: The microbiome and pneumococcal carriage – emerging insights

MTE 11: Pro and con – adjunctive macrolide for CAP

MTE 12: Hib Initiative Reunion Session

Robert Austrian Lecture and Awards

Networking Dinner

Plenary 07: Combatting antimicrobial resistance in pneumonia and pneumococcal disease

Plenary 08: Pneumococcal carriage – guidelines, gaps, and global use

Plenary 09: Extended-valency pneumococcal vaccines – opportunities and immunological challenges

Closing Ceremony